Akebia Therapeutics, Inc. AKBA
0.39 USD -0.04 (-8.71%)
Regular-session close
0.40 +0.01 +3.50%
After hours · Nov 20, 7:50 PM ET
0.3849 Day range 0.4331
0.361 52-week range 1.73
- YTD
- -76.06%
- 1 year
- -74.97%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 236.20M | 160.18M | 194.62M | 292.48M | 211.65M | |
| 236.20M | 160.18M | 194.62M | 292.48M | 211.65M | |
| 39.46M | 63.18M | 74.15M | 85.57M | 150.67M | |
| 196.73M | 97.00M | 120.47M | 206.92M | 60.98M | |
| 169.84M | 144.25M | 163.49M | 284.52M | 325.48M | |
| 62.36M | 37.65M | 63.08M | 129.99M | 147.85M | |
| 107.48M | 106.55M | 100.23M | 138.60M | 174.14M | |
| 26.89M | -47.25M | -43.02M | -77.60M | -264.50M | |
| 24.18M | 18.18M | 6.03M | 15.69M | 19.94M | |
| 1.62M | 0 | 0 | 0 | 0 | |
| -5.34M | -69.41M | -51.92M | -94.23M | -282.02M | |
| -5.34M | -69.41M | -51.92M | -94.23M | -282.02M | |
| -5.34M | -69.41M | -51.92M | -94.23M | -282.02M | |
| -5.34M | -69.41M | -51.92M | -94.23M | -282.02M | |
| -0.02 | -0.33 | -0.28 | -0.52 | -1.70 | |
| -0.02 | -0.33 | -0.28 | -0.52 | -1.70 | |
| -0.02 | -0.33 | -0.28 | -0.52 | -1.70 | |
| 20.46M | -51.23M | -45.89M | -78.54M | -262.09M | |
| 20.46M | -51.23M | -45.89M | -78.54M | -262.09M | |
| 257.16M | 210.95M | 187.47M | 182.78M | 165.95M | |
| 257.16M | 210.95M | 187.47M | 182.78M | 165.95M |
